WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Cruise worker 'murders newborn son on board ship': Shocked co
Former Michigan House leader, wife plead not guilty to misusing political funds
I was the least favourite grandchild
Alvarez and Munguia unusually polite to each other leading up to all
Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
Three signs Princess Charlotte's birthday portrait, taken by Kate Middleton, was not retouched
The Rolling Stones are set to rock New Orleans Jazz Fest after two previous tries
Mississippi high court declines to rule on questions of public funds going to private schools
Amir Khan's £11.5m luxury wedding venue finally hosts its first marriage: Bride arrives on horse
MLB extends Draft League through 2030 season and announces plan to expand to eight teams